Cargando…

Identifying Breast Cancer Recurrence in Administrative Data: Algorithm Development and Validation

Breast cancer recurrence is an important outcome for patients and healthcare systems, but it is not routinely reported in cancer registries. We developed an algorithm to identify patients who experienced recurrence or a second case of primary breast cancer (combined as a “second breast cancer event”...

Descripción completa

Detalles Bibliográficos
Autores principales: Holloway, Claire M. B., Shabestari, Omid, Eberg, Maria, Forster, Katharina, Murray, Paula, Green, Bo, Esensoy, Ali Vahit, Eisen, Andrea, Sussman, Jonathan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9406366/
https://www.ncbi.nlm.nih.gov/pubmed/36005162
http://dx.doi.org/10.3390/curroncol29080424
_version_ 1784774103298736128
author Holloway, Claire M. B.
Shabestari, Omid
Eberg, Maria
Forster, Katharina
Murray, Paula
Green, Bo
Esensoy, Ali Vahit
Eisen, Andrea
Sussman, Jonathan
author_facet Holloway, Claire M. B.
Shabestari, Omid
Eberg, Maria
Forster, Katharina
Murray, Paula
Green, Bo
Esensoy, Ali Vahit
Eisen, Andrea
Sussman, Jonathan
author_sort Holloway, Claire M. B.
collection PubMed
description Breast cancer recurrence is an important outcome for patients and healthcare systems, but it is not routinely reported in cancer registries. We developed an algorithm to identify patients who experienced recurrence or a second case of primary breast cancer (combined as a “second breast cancer event”) using administrative data from the population of Ontario, Canada. A retrospective cohort study design was used including patients diagnosed with stage 0-III breast cancer in the Ontario Cancer Registry between 1 January 2009 and 31 December 2012 and alive six months post-diagnosis. We applied the algorithm to healthcare utilization data from six months post-diagnosis until death or 31 December 2013, whichever came first. We validated the algorithm’s diagnostic accuracy against a manual patient record review (n = 2245 patients). The algorithm had a sensitivity of 85%, a specificity of 94%, a positive predictive value of 67%, a negative predictive value of 98%, an accuracy of 93%, a kappa value of 71%, and a prevalence-adjusted bias-adjusted kappa value of 85%. The second breast cancer event rate was 16.5% according to the algorithm and 13.0% according to manual review. Our algorithm’s performance was comparable to previously published algorithms and is sufficient for healthcare system monitoring. Administrative data from a population can, therefore, be interpreted using new methods to identify new outcome measures.
format Online
Article
Text
id pubmed-9406366
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-94063662022-08-26 Identifying Breast Cancer Recurrence in Administrative Data: Algorithm Development and Validation Holloway, Claire M. B. Shabestari, Omid Eberg, Maria Forster, Katharina Murray, Paula Green, Bo Esensoy, Ali Vahit Eisen, Andrea Sussman, Jonathan Curr Oncol Article Breast cancer recurrence is an important outcome for patients and healthcare systems, but it is not routinely reported in cancer registries. We developed an algorithm to identify patients who experienced recurrence or a second case of primary breast cancer (combined as a “second breast cancer event”) using administrative data from the population of Ontario, Canada. A retrospective cohort study design was used including patients diagnosed with stage 0-III breast cancer in the Ontario Cancer Registry between 1 January 2009 and 31 December 2012 and alive six months post-diagnosis. We applied the algorithm to healthcare utilization data from six months post-diagnosis until death or 31 December 2013, whichever came first. We validated the algorithm’s diagnostic accuracy against a manual patient record review (n = 2245 patients). The algorithm had a sensitivity of 85%, a specificity of 94%, a positive predictive value of 67%, a negative predictive value of 98%, an accuracy of 93%, a kappa value of 71%, and a prevalence-adjusted bias-adjusted kappa value of 85%. The second breast cancer event rate was 16.5% according to the algorithm and 13.0% according to manual review. Our algorithm’s performance was comparable to previously published algorithms and is sufficient for healthcare system monitoring. Administrative data from a population can, therefore, be interpreted using new methods to identify new outcome measures. MDPI 2022-07-28 /pmc/articles/PMC9406366/ /pubmed/36005162 http://dx.doi.org/10.3390/curroncol29080424 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Holloway, Claire M. B.
Shabestari, Omid
Eberg, Maria
Forster, Katharina
Murray, Paula
Green, Bo
Esensoy, Ali Vahit
Eisen, Andrea
Sussman, Jonathan
Identifying Breast Cancer Recurrence in Administrative Data: Algorithm Development and Validation
title Identifying Breast Cancer Recurrence in Administrative Data: Algorithm Development and Validation
title_full Identifying Breast Cancer Recurrence in Administrative Data: Algorithm Development and Validation
title_fullStr Identifying Breast Cancer Recurrence in Administrative Data: Algorithm Development and Validation
title_full_unstemmed Identifying Breast Cancer Recurrence in Administrative Data: Algorithm Development and Validation
title_short Identifying Breast Cancer Recurrence in Administrative Data: Algorithm Development and Validation
title_sort identifying breast cancer recurrence in administrative data: algorithm development and validation
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9406366/
https://www.ncbi.nlm.nih.gov/pubmed/36005162
http://dx.doi.org/10.3390/curroncol29080424
work_keys_str_mv AT hollowayclairemb identifyingbreastcancerrecurrenceinadministrativedataalgorithmdevelopmentandvalidation
AT shabestariomid identifyingbreastcancerrecurrenceinadministrativedataalgorithmdevelopmentandvalidation
AT ebergmaria identifyingbreastcancerrecurrenceinadministrativedataalgorithmdevelopmentandvalidation
AT forsterkatharina identifyingbreastcancerrecurrenceinadministrativedataalgorithmdevelopmentandvalidation
AT murraypaula identifyingbreastcancerrecurrenceinadministrativedataalgorithmdevelopmentandvalidation
AT greenbo identifyingbreastcancerrecurrenceinadministrativedataalgorithmdevelopmentandvalidation
AT esensoyalivahit identifyingbreastcancerrecurrenceinadministrativedataalgorithmdevelopmentandvalidation
AT eisenandrea identifyingbreastcancerrecurrenceinadministrativedataalgorithmdevelopmentandvalidation
AT sussmanjonathan identifyingbreastcancerrecurrenceinadministrativedataalgorithmdevelopmentandvalidation